| INTRODUCTION
Potentially malignant disorders (PMD) are clinically discernible oral diseases, most frequently localised mucosal disorders such as leukoplakia, erythroplakia and erythroleukoplakia, but also widespread abnormalities such as proliferative verrucous leukoplakia (PVL) or controversially oral lichenoid lesions (OLL) that precede in an unpredictable manner invasive oral squamous cell carcinoma (OSCC) development.
1,2 Contemporary PMD management is based upon initial incision biopsy to provide histological assessment and severity grading of underlying tissue disorganisation and dysmaturation changes characteristic of epithelial dysplasia, followed by targeted surgical excision for definitive diagnosis and treatment of lesions deemed "high risk" for malignant transformation (MT). [3] [4] [5] Whilst systematic review has estimated an overall 12% MT risk over a mean period of 4.3 years, 6 clinicopathological features associated with highest cancer risk include appearance of erythroplakia, erythroleukoplakia or PVL, mucosa exhibiting severe dysplastic change and origin on ventrolateral tongue and floor of mouth sites. [3] [4] [5] [6] In addition, in relation to OLL, we have demonstrated persistence of disease post-treatment with poor long-term outcome, including an increased MT risk, often in the absence of recognisable dysplasia. 3, 7, 8 Whilst strict definition remains elusive, OLL are generally characterised histopathologically by the presence of lichenoid inflammation (LI), a band-like lymphohistiocytic infiltrate subjacent to hyperplastic or dysplastic epithelium; the latter finding is sometimes termed "lichenoid dysplasia". [9] [10] [11] However, multiple white hyperkeratotic lesions with a verrucous epithelial hyperkeratosis and "interface mucositis" are also features of PVL and, by mimicking OLL, contribute to diagnostic confusion. 9 Long-term patient follow-up data are required to improve our understanding of the natural history of these disorders and to try to resolve the conundrum surrounding both diagnosis and management. 3 In a series of recent papers, we have defined and characterised clinical outcome data for a 590 PMD patient cohort undergoing standardised interventional CO 2 laser treatment, primarily excision surgery but also ablation for small or less dysplastic lesions especially at gingiva and alveolar sites. 3, 5, 12 Post-treatment, 438 patients from this cohort (74.2%) were disease-free (DF), 53 had persistent PMD disease and 99 (16.8%) exhibited either unexpected OSCC on excision (71% or 12%) or developed SCC subsequently (28% or 4.8%) during a mean 7.3-year follow-up period. 3, 5, 12 The specific purpose of this study was to revisit this 590 PMD cohort and determine the prevalence of OLL and PVL in the population and to distinguish clinicopathological features and post-treatment outcome data that might characterise and predict clinical behaviour for these specific PMD subgroups. 
| ME TH OD

| Oral lichenoid lesions
| Proliferative verrucous leukoplakia
| Diagnostic discrepancy
In 10 patients, 3 of which are highlighted in Table 1 and 7 in   Table 2 , histopathological diagnoses of LI and PVL were both ascribed. In 7 cases, this was a "same-site" discrepancy between initial incision and subsequent excision biopsy diagnoses, whilst in another 3, further "new-site" disease developed and was diagnosed as PVL or LI in a patient previously categorised by the alternate diagnosis.
| Statistical analyses
In terms of significant differences, OLL were usually seen in younger patients (logistic regression: Wald v 2 = 7.09; P = .008) and more likely than PVL to present as erythroplakia or erythroleukoplakia (chisquared test: v 2 = 9.303; P = .003). Whilst OLL presented most frequently on ventrolateral tongue and floor of mouth mucosa, PVL was more evenly distributed amongst all oral sites including tongue dorsum and fauces which were rarely affected by OLL (chi-squared test: v 2 = 16.018; P = .013). leukoplakia on the ventrolateral tongue and floor of mouth were more likely to be DF post-laser, were significant influences (P = .01 and P = .04, respectively). Laser excision surgery was more effective than ablation techniques in achieving DF status (P = .04).
| DISCUSSION
This study has attempted a detailed review of the presentation and clinical outcome of 198 PMD patients diagnosed as OLL or PVL.
Patients were identified from a previously reported cohort, which benefited from uniform diagnoses, consistent treatment intervention, long-term surveillance and documented clinical outcome.
3,5,12
| Oral lichenoid lesions
Twenty per cent of PMD lesions in this cohort were diagnosed as OLL; this is similar to previous reports suggesting that up to 29% of PMD may exhibit lichenoid features. Although OLL are classically described as solitary erythroleukoplakic lesions, mimicking the appearance of mucosal lichen planus, strict definition remains elusive. 9 Over 80% of OLL in this study appeared as leukoplakia and were particularly common on ventrolateral tongue, floor of mouth and labio-buccal mucosa sites; most were excised by laser surgery.
Upon microscopic examination, 72% of OLL in the study exhibited dysplasia most frequently mild or moderate in extent. Whilst the diagnostic term "lichenoid dysplasia" has been proposed, raising specific concerns regarding long-term prognosis and increased MT risk, this terminology is not uniformly supported in the literature. 9, 11, 13 It remains unclear whether LI drives MT, similar to chronic inflammation in the colonic cancer model, or is an immune response to atypical oral epithelium 1, 9 ; the latter hypothesis is favoured by the authors of this study.
Whilst the prognostic significance of OLL has been debated for many years and is still controversial, there is increasing recognition in clinical practice that isolated OLL, especially those arising on the tongue, should be considered at high risk of MT and treated by interventional surgery. 5, 14 Ultimately, patients with OLL in this study were less likely to be DF post-treatment than those in the overall PMD cohort (69.5% vs 74.2%, respectively). MT following laser treatment affected 2 patients (1.7%), which is similar to the 1.09%-2.1% range quoted in the literature.
9,15
It has not been common practice to continuously follow-up patients with OLL, although some authors now recommend this practice in specialist clinics to monitor for early cancerous change. 7, 8, 14 The findings of this study certainly support this approach.
| Proliferative verrucous leukoplakia
Proliferative verrucous leukoplakia was diagnosed in 13.6% of the study cohort, much higher than the previously quoted prevalence of 0.1% in the UK population. 16 Lesions were predominantly leukoplakic in appearance (97.5%) with a high predilection for labio-buccal and gingival/alveolar sites (40%) and exhibiting more widespread mucosal involvement than OLL. A higher percentage of PVL (85%)
showed dysplasia compared with OLL, although the majority were diagnosed as mild. Clinical outcomes were very similar to OLL, with DF status confirmed in 65% of patients and 2 (2.5%) progressing to OSCC, considerably better than previously reported 15% DF and 70% MT rates post-PVL treatment and strongly supportive of the efficacy of CO 2 laser as a treatment modality.
3,17
Traditionally, PVL diagnoses were made late during PMD presentation once spread to different sites, high recurrence following treatment and MT all become apparent. Increasingly, specialist pathologists have attempted earlier and more objective diagnoses for verrucous hyperplastic lesions considered part of the PVL spectrum, probably explaining their increased diagnoses during the latter years of this study. 3, 16 Salient criteria supporting PVL diagnoses have included the following: patients older than 60 years, a female:male ratio of 4:1, limited use of tobacco and alcohol, multiple-site disease and progressive clinical and histopathological features confirmed during follow-up. 9, 16 Although PVL patients in this study were seen to be older, they displayed a more equal sex distribution, were active users of tobacco and alcohol, and were diagnosed as "single-site" disease.
It may be that these clinical presentations were at an early phase in PVL disease progression.
| Diagnostic discrepancy or disease evolution?
In 10 patients (5%), features of both OLL and PVL were identified, primarily in "same-site" lesions at different time points. Whether this represents a discrepancy between incision and excision biopsy diagnoses, which is known to affect nearly 50% of PMD cases, 3 or is representative of disease evolution remains unknown. Histopathologically, PVL is known to exhibit a continuum of morphological change, passing through an initial hyperkeratosis phase usually without dysplasia, through verrucous hyperplasia leading on to verrucous carcinoma and invasive OSCC. 18 Complicating the early phase of PVL is the presence of lymphocytic infiltrates in the immediate subepithelial region similar to OLL. 9, 17, 19 It is not an unreasonable hypothesis, therefore, that OLL and PVL may be part of the same PMD continuum. 
| CONCLUSION S
